Research carried out at the National Institute of Allergy and Infectious Diseases (NIAID) in the USA suggests that an end to the HIV/AIDS pandemic will only be possible with the development of an effective HIV vaccine.
NIAID director Anthony Fauci writes that, while existing treatments are effective at suppressing HIV and preventing viral transmission, substantial gaps in implementation remain, and are likely to be difficult to eliminate.
The report notes that, “globally, more than 17 million people living with HIV are not receiving antiretroviral therapy. This is compounded by the continuing high rate of new infections, an estimated 1.8 million worldwide in 2016 alone.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze